Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose

Clinical trial NCT07422285 · COMPLETED

Trial details

NCT number: NCT07422285
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants Pharmacokinetics

Start date: 2026-01-16
Primary completion: 2026-07-24
Enrollment: 405

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.